Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort studyLaura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-BruinsmaSee the full list of authors
5 April 2022
Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responsesBenazir Saleem, Rebecca L Ross, Lesley-Anne Bissell, Aamir Aslam, Kulveer Mankia, Laurence Duquenne, Diane Corsadden, Clive Carter, Pam Hughes, Fatima A Nadat, Panji Mulipa, Mark Lobb, Brendan Clarke, Katie Mbara, Ruth MortonSee the full list of authors
1 April 2022
Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapyDaniel Sidler, Alexander Born, Simeon Schietzel, Michael P Horn, Daniel Aeberli, Jennifer Amsler, Burkhard Möller, Linet M Njue, Cesare Medri, Anne Angelillo-Scherrer, Luca Borradori, S. Morteza Seyed Jafari, Susanne Radonjic-Hoesli, Andrew Chan, Robert HoepnerSee the full list of authors
31 March 2022
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseasesGeorge E Fragoulis, Anastasios Karamanakos, Aikaterini Arida, Vasiliki-Kalliopi Bournia, Gerasimos Evangelatos, Antonis Fanouriakis, Kalliopi Fragiadaki, Evrydiki Kravvariti, Katerina Laskari, Stylianos Panopoulos, Nikolaos Papazoglou, Maria Pappa, Maria G Tektonidou, Petros P Sfikakis
4 March 2022
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccinationPaola Adele Lonati, Caterina Bodio, Mariangela Scavone, Giuliana Martini, Elisa Pesce, Alessandra Bandera, Andrea Lombardi, Maria Gerosa, Franco Franceschini, Angela Tincani, Gianmarco Podda, Sergio Abrignani, Renata Grifantini, Marco Cattaneo, Maria Orietta BorghiSee the full list of authors
7 February 2022
Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patientsSimeon Schietzel, Manuel Anderegg, Andreas Limacher, Alexander Born, Michael P Horn, Britta Maurer, Cedric Hirzel, Daniel Sidler, Matthias B Moor
3 February 2022
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapyKathleen MM Vanni, Naomi J Patel, Michael DiIorio, Emily Kowalski, Grace Qian, Claire E Cook, Susan Y Ritter, Zachary S Wallace, Jeffrey A Sparks
2 February 2022
Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseasesCristiana Sieiro Santos, Sara Calleja Antolin, Clara Moriano Morales, Juan Garcia Herrero, Elvira Diez Alvarez, Fernando Ramos Ortega, Jose G Ruiz de Morales
5 January 2022
Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitorsVincenzo Venerito, Pasquale Stefanizzi, Marco Fornaro, Fabio Cacciapaglia, Silvio Tafuri, Simone Perniola, Florenzo Iannone, Giuseppe Lopalco
5 January 2022
Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER studyJose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, María Ester Ruiz-Lucea, Laura López-Vives, Cristina Bohorquez, Julia Martinez-Barrio, Gema Bonilla, Paloma Vela, María Jesús García-Villanueva, María Teresa Navío-Marco, Marina Pavía, María Galindo, Celia Erausquin, Miguel A Gonzalez-GaySee the full list of authors
9 December 2021
